Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.

Daily low-dose aspirin reduced the risk for colorectal cancer recurrence by roughly half in patients with mutations in the ...

Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations in the PI3K ...

In an era dominated by pricey, high-tech drugs, the humble aspirin had a practice-changing impact on colorectal cancer (CRC) ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

Three-year results from the ALASCCA trial (NCT02647099), presented at the 2025 ASCO Gastrointestinal Cancer Symposium, showed ...

Many Americans don't see anything wrong with taking daily low-dose aspirin, even though experts have concluded its risks ...

A new study published in the Nature Scientific Reports highlighted the potential benefits of aspirin in reducing biochemical ...

Health guidelines now advise against the practice for most people, because it increases likelihood of brain and ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of ...

Adjuvant treatment with aspirin is associated with a lower risk of recurrence at 3 years in CRC patients with PI3K pathway ...

Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.